Broad-spectrum Human Papillomavirus Vaccine (BravoVax )
广谱人乳头瘤病毒疫苗（博沃生物）
Report date: 2022/12/26 10:02:35
Base Information
Drug NameBroad-spectrum Human Papillomavirus Vaccine (BravoVax )
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWuhan Bravovax Co Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A